SCHEMBL31014203

SCHEMBL31014203

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(N)=O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.60
▸ MAPK9 P45984 1/20 0.60
▸ MAPK10 P53779 1/20 0.60
▸ IL23R Q5VWK5 1/20 0.54
▸ CALCR P30988 3/20 0.53
▸ EIF4E P06730 2/20 0.52
▸ EIF4EBP1 Q13541 2/20 0.52
▸ KEAP1 Q14145 2/20 0.51
▸ TFPI P10646 2/20 0.50
▸ NMUR2 Q9GZQ4 1/20 0.49
▸ NMUR1 Q9HB89 1/20 0.49
▸ GLP1R P43220 1/20 0.48
▸ OXTR P30559 1/20 0.48
▸ CTSL P07711 1/20 0.48
▸ CTSH P09668 1/20 0.48
▸ CTSS P25774 1/20 0.48
▸ CTSK P43235 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31014198 0.97 MAPK8 (0.56) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL30248429 0.97 MAPK8 (0.62) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL31014196 0.95 MAPK8 (0.60) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL30248733 0.95 MAPK8 (0.58) MAPK8MAPK9MAPK10CALCRKEAP1
SCHEMBL25027403 0.94 MAPK8 (0.53) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL25028492 0.94 MAPK8 (0.53) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL25028399 0.93 MAPK8 (0.53) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL31014197 0.93 MAPK8 (0.56) MAPK8MAPK9MAPK10CALCRKEAP1
SCHEMBL30248579 0.92 MAPK8 (0.63) MAPK8MAPK9MAPK10IL23RCALCR
SCHEMBL30248619 0.89 MAPK8 (0.59) MAPK8MAPK9MAPK10CALCRKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352069-A1 SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHENZHEN WINKEY TECHNOLOGY CO., LTD. (CN) 2024-10-24 — — US claimed
CN-116829169-B Synthetic peptides, compositions and uses thereof 深圳市维琪科技股份有限公司 2024-12-27 — — CN disclosed
US-20240352069-A1 SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHENZHEN WINKEY TECHNOLOGY CO., LTD. (CN) 2024-10-24 — — US disclosed
EP-4385516-A1 SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Shenzhen Winkey Technology Co., Ltd. (CN) 2024-06-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240352069-A1 SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF VIP, MC1R, PROKR1 MAPK8 1840/4885MAPK9 934/4885MAPK10 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback